Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Phase NA Completed
30 enrolled
SICG
Phase NA Completed
36 enrolled 16 charts
BMT
Phase NA Completed
10 enrolled
BRUOG-407
Phase NA Completed
18 enrolled 8 charts
BMT CTN 1702
Phase NA Completed
1,753 enrolled
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Phase NA Completed
13 enrolled
Poly-CO
Phase NA Completed
60 enrolled
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia
Phase NA Completed
30 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
BioScoreSMP
Phase NA Completed
133 enrolled
MargheRITA
Phase NA Completed
124 enrolled
EVAADE
Phase NA Completed
15 enrolled
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
Phase NA Completed
10 enrolled 11 charts
The EMPATHY Pilot Study
Phase NA Completed
94 enrolled 13 charts
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms
Phase NA Completed
102 enrolled
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
Phase NA Completed
25 enrolled
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
Phase NA Completed
47 enrolled
HCTDiet
Phase NA Completed
40 enrolled
Mini-allo
Phase NA Completed
36 enrolled
Unrelated Donor Stem Cell Transplantation
Phase NA Completed
64 enrolled
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Phase NA Completed
10 enrolled
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Phase NA Completed
281 enrolled 24 charts
CAR-LMC
Phase NA Completed
53 enrolled
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
Phase NA Completed
125 enrolled 9 charts
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
Phase NA Completed
48 enrolled 7 charts
Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects
Phase NA Completed
38 enrolled
IM-TMI
Phase NA Completed
14 enrolled 14 charts
Unrelated Umbilical Cord Blood (UBC)Transplantation
Phase NA Completed
34 enrolled 10 charts
PLASMYC
Phase NA Completed
138 enrolled
Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Phase NA Completed
87 enrolled 10 charts
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Phase NA Completed
18 enrolled 7 charts
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase NA Completed
8 enrolled 12 charts
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life
Phase NA Completed
99 enrolled
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Phase NA Completed
39 enrolled 13 charts
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase NA Completed
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Phase NA Completed
10 enrolled
TAR
Phase NA Completed
7 enrolled 8 charts
NUTRIENT
Phase NA Completed
30 enrolled
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Phase NA Completed
876 enrolled
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Phase NA Completed
160 enrolled
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Phase NA Completed
41 enrolled
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Phase NA Completed
29 enrolled
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
Phase NA Completed
17 enrolled
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery
Phase NA Completed
39 enrolled
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Phase NA Completed
62 enrolled 14 charts
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Phase NA Completed
68 enrolled
EvaTryMS
Phase NA Completed
250 enrolled
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
Phase NA Completed
129 enrolled
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Phase NA Completed
100 enrolled 10 charts
The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients
Phase NA Completed
128 enrolled